|
Title
|
Publication Date
|
Price
|
Relevance
|
Drug Delivery Devices Market Outlook in the United States to 2016
Inhalation Systems, Infusion Systems and Others
|
Aug 2010 |
£1,580 |
100% |
Drug Delivery Devices Market Outlook in United States to 2017
Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections
|
May 2011 |
£1,580 |
99% |
United Sates Drug Delivery Devices Investment Opportunities
Analysis and Forecasts to 2015
|
Mar 2009 |
£1,580 |
99% |
|
North America Drug Delivery Devices Market Outlook to 2017
|
May 2011 |
£2,215 |
99% |
|
North America Drug Delivery Devices Market Outlook to 2016
|
Nov 2010 |
£2,215 |
99% |
United States Drug Delivery Devices Medical Equipment Industry Report
Detailed Analysis of the Medical Equipment & Medical Devices Market Covering Infusion Systems, Inhalation Systems and Needle Free Injections Medical Equipment and Supplies
|
Apr 2008 |
£1,895 |
99% |
United States Drug Delivery Devices Investment Opportunities
Analysis and Forecasts to 2012
|
Sep 2008 |
£1,895 |
99% |
|
North America Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2012
|
Jan 2009 |
£1,895 |
98% |
|
Global Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015
|
Mar 2009 |
£2,530 |
97% |
|
US Drug Delivery Devices Industry Report
|
Mar 2008 |
£1,895 |
97% |
Neurological Disorders - Physician Perspective
2008 U.S. Drug Delivery
|
Nov 2010 |
£6,325 |
96% |
|
Consort Medical plc Market Share Analysis
|
Jun 2011 |
£630 |
93% |
Novartis Medical Nutrition
Market Share Analysis
|
Oct 2010 |
£630 |
93% |
GlaxoSmithKline plc
Market Share Analysis
|
Oct 2010 |
£630 |
92% |
|
Global Drug Delivery Devices Industry Report
|
Mar 2008 |
£2,530 |
92% |
|
Novartis Medical Nutrition Market Share Analysis
|
Oct 2010 |
£630 |
92% |
Ophthalmic Pharmaceutical Drugs
A Global Market Perspective
|
Nov 2009 |
£1,895 |
92% |
Hospira, Inc
Market Share Analysis
|
Nov 2010 |
£630 |
92% |
Boehringer Ingelheim GmbH
Market Share Analysis
|
Sep 2010 |
£630 |
92% |
|
Nanobiotechnology
|
Feb 2011 |
£2,815 |
91% |
Sepracor Inc.
Market Share Analysis
|
Oct 2010 |
£630 |
91% |
|
GlaxoSmithKline plc Market Share Analysis
|
Oct 2010 |
£630 |
91% |
Needle-Free Drug Delivery
The Market for Alternatives to Needle-Based Systems for Vaccine and Biologics
|
Jul 2011 |
£2,215 |
91% |
|
Boehringer Ingelheim GmbH Market Share Analysis
|
Sep 2010 |
£630 |
90% |
|
The Top 100 Drug Delivery Companies Worldwide
|
Jan 2004 |
£525 |
90% |
Chemotherapy Market Insights, 2006-2016
A Critical Analysis of Cancer Research, Treatments, Pipelines, and Commercial Opportunities
|
Apr 2006 |
£1,900 |
90% |
|
Sepracor Inc. Market Share Analysis
|
Oct 2010 |
£630 |
90% |
Ophthalmological Therapeutics
Pipelines, Delivery Technologies, and Markets
|
Jan 2008 |
£710 |
89% |
|
United States Medical Equipment Markets: Investment Opportunities, Analysis and Forecasts in Medical Devices to 2012
|
Jan 2009 |
£1,265 |
88% |
|
UK Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2012
|
May 2008 |
£1,895 |
88% |
